Hiroyuki Watanabe
- Pharmacology top 1%
- Cholinesterase and Neurodegenerative Diseases 11
- Organic Chemistry top 2%
- Physiology top 2%
- Alzheimer's disease research and treatments 51
- Biochemistry top 2%
- Endocrinology top 5%
-
- Radiopharmaceutical Chemistry and Applications 32
-
- Neuroscience and Neuropharmacology Research 17
-
- Peptidase Inhibition and Analysis 11
-
- S100 Proteins and Annexins 10
-
- Prostate Cancer Treatment and Research 10
-
- Nanoplatforms for cancer theranostics 9
Hiroyuki Watanabe
209 papers receiving 5.3k citations
Peers
Comparison fields: 5 of 145
- Pharmacology 763
- Organic Chemistry 1.2k
- Physiology 993
- Biochemistry 190
- Endocrinology 151
Countries citing papers authored by Hiroyuki Watanabe
This map shows the geographic impact of Hiroyuki Watanabe's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Hiroyuki Watanabe with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Hiroyuki Watanabe more than expected).
Fields of papers citing papers by Hiroyuki Watanabe
This network shows the impact of papers produced by Hiroyuki Watanabe. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Hiroyuki Watanabe. The network helps show where Hiroyuki Watanabe may publish in the future.
Co-authorship network
The 25 scholars most cited alongside Hiroyuki Watanabe, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2025 | 0 | |
| 2 | 2024 | 1 | |
| 3 | 2024 | 2 | |
| 4 | 2024 | 3 | |
| 5 | 2024 | 2 | |
| 6 | 2024 | 0 | |
| 7 | 2024 | 0 | |
| 8 | 2023 | 8 | |
| 9 | 2022 | 5 | |
| 10 | 2022 | 1 | |
| 11 | 2021 | 3 | |
| 12 | 2021 | 13 | |
| 13 | 2021 | 24 | |
| 14 | 2020 | 3 | |
| 15 | 2020 | 9 | |
| 16 | 2020 | 4 | |
| 17 | 2020 | 30 | |
| 18 | 2019 | 12 | |
| 19 | 2018 | 11 | |
| 20 | 1966 | 1 |
About Hiroyuki Watanabe
Hiroyuki Watanabe is a scholar working on Physiology, Radiology, Nuclear Medicine and Imaging and Organic Chemistry, having authored 226 papers that have together received 5.4k indexed citations. Recurring topics across this work include Alzheimer's disease research and treatments (51 papers), Radiopharmaceutical Chemistry and Applications (32 papers), Neuroscience and Neuropharmacology Research (17 papers), Peptidase Inhibition and Analysis (11 papers), Cholinesterase and Neurodegenerative Diseases (11 papers), S100 Proteins and Annexins (10 papers), Prostate Cancer Treatment and Research (10 papers) and Nanoplatforms for cancer theranostics (9 papers). The work is most often cited by research in Pharmacology (763 citations), Organic Chemistry (1.2k citations) and Physiology (993 citations). Hiroyuki Watanabe has collaborated with scholars based in Japan, Thailand and Indonesia. Frequent co-authors include Masahiro Ono, Hideo Saji, Haruo Seto, Tomohisa Kuzuyama, Hiroyuki Kimura, Shunji Takahashi, Shimpei Iikuni, Ichiro Minami, Jiro Tsuji and Satoshi Kawata. Their work appears in journals such as Bioorganic & Medicinal Chemistry Letters, Bioorganic & Medicinal Chemistry, Journal of Medicinal Chemistry, Molecular Pharmaceutics and ACS Medicinal Chemistry Letters.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.